ArticleTreatment strategies. Hematology2012

TIMP-2: An Endogenous Angiogenesis Inhibitor with Distinct Antitumoral Properties.

Dimitra Bourboulia et al.PubMed ↗Full text ↗

No numbers read from the abstract.